Skip to main content
INOVIQ LTD logo

INOVIQ LTD — Investor Relations & Filings

Ticker · IIQ ISIN · AU0000196149 ASX Professional, scientific and technical activities
Open in API
Filings indexed 858 across all filing types
Latest filing 2006-05-14 Regulatory Filings
Country AU Australia
Listing ASX IIQ

About INOVIQ LTD

https://www.inoviq.com

INOVIQ LTD specializes in the development and commercialization of next-generation exosome and precision diagnostics. The company focuses on innovative solutions for the early detection and monitoring of cancer and other diseases. Its proprietary technology portfolio includes EXO-NET, a high-throughput exosome capture tool designed for research and clinical applications, and the SubB2M platform, which utilizes an engineered protein to detect the pan-cancer biomarker Neu5Gc. The company also provides the hTERT test for bladder cancer monitoring. These technologies facilitate non-invasive liquid biopsy tests aimed at improving patient outcomes through high sensitivity and specificity. The core business activities encompass the creation of diagnostic tools and research reagents for the global healthcare and life sciences sectors, emphasizing precision medicine and early intervention.

Recent filings

Filing Released Lang Actions
Notice of General Meeting 7 pages ?Kb
Regulatory Filings
2006-05-14 English
BDO Independent Experts Report 25 pages ?Kb
Regulatory Filings
2006-05-14 English
RSG Global Independent Experts Report 74 pages ?Kb
Audit Report / Information Classification · 95% confidence The document is titled 'Independent Technical Valuation of the Mineral Assets of Eurogold Limited' and is prepared by RSG Global on behalf of BDO Chartered Accountants and Advisers. It contains detailed technical and valuation information about mineral assets, including exploration properties, processing operations, geology, metallurgy, and valuation summaries. The content is technical and valuation-focused rather than financial performance or management discussion. It is not an annual report, audit report, earnings release, or any typical financial filing. It is a standalone technical valuation report prepared for accounting and advisory purposes. This fits best under the category of Audit Report / Information (AR), which includes applied accounting principles and results of internal or regulatory stress tests, and can encompass technical valuation reports prepared for audit or advisory purposes. The document is substantive and lengthy (15,000 characters), so it is not a mere announcement or publication notice. Therefore, the classification is AR with high confidence.
2006-05-14 English
Becoming a substantial holder 3 pages ?Kb
Regulatory Filings
2006-05-04 English
Change of Director's Interest Notice 2 pages ?Kb
Regulatory Filings
2006-05-02 English
Third Quarter Activities & Cashflow Report 8 pages ?Kb
Regulatory Filings
2006-04-30 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.